MedPath

Development of cytological analysis of pancreatic cancer using homology technology

Not Applicable
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000044462
Lead Sponsor
Mie University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
180
Inclusion Criteria

Not provided

Exclusion Criteria

Cases that the principal investigator / coordinator deems inappropriate for inclusion in the study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The sensitivity, specificity, and correct diagnosis rate of the homology profile method are calculated by comparing the analysis results of each sample by the homology profile method with the final pathological diagnosis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath